F552 in Florida. Pick another state for the same tag.
Against expectation — 2025
Florida cites F552 less often than its own record predicts
Versus expected share0.42×
0.42 times the national share — cited less often here than elsewhere.
Share of Florida citations0.23%
Of every deficiency written in Florida in 2025, this is the portion that was F552.
Florida0.23%
National0.54%
Share of all citations that were F552.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Florida surveyors wrote
F552 findings written in Florida, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
J · Immediate jeopardy, isolatedApril 18, 2026
Based on observation, interview, and record review, the facility failed to coordinate, communicate, and document the change in diabetic treatment plan for a chronically ill resident who required a surrogate for decision making, (#1). This affected 1 out of 8 diabetic residents whose treatment plans were reviewed, out of 43 residents in the facility with a diagnosis of diabetes. Resident #1 and her representative were not informed of the risks associated with not receiving diabetic care and were not given the choice to make an informed decision on the treatment plan. …
D · No harm, potential for more than minimal, isolatedAugust 13, 2026
Based on interview and record review, the facility failed to ensure informed consent was obtained prior to the administration of psychotropic medications for 2 of 6 residents reviewed for psychotropic medication use. (Residents #4 and #11) The findings include:
1. On 8/12/26 at approximately 11:30 AM, a record review for Resident #4 revealed a physician's order of Paroxetine 40 mg once a day for depression, Trazodone 100 mg once a day for depression, Divalproex 500 mg twice a day for Bipolar Disorder (lifelong mental health conditions defined by severe shifts in mood, energy, and activity levels), and Risperidone 2 mg three times a day for Schizophrenia (a severe, chronic brain disorder that affects how a person thinks, feels, and acts). …
B · No harm, potential for minimal, patternApril 30, 2026
Based on observation, interview and record review, the facility failed to obtain informed consents for use of psychotropic medications for 1 of 5 sampled residents reviewed for unnecessary medications and 2 of 2 sampled residents reviewed for accidents, Residents #41, #42 and #95.The findings included:The facility's policy titled, Informed Consent for Psychotropic Drugs, undated, revealed a psychoactive drug is any drug that affects brain activities associated with mental processes and behavior, including but not limited to antipsychotics (e.g., haloperidol risperidone), antidepressants, anxiolytics, hypnotics, mood stabilizers, anticonvulsants, central nervous system agents, muscle relaxers, anticholinergics, antihistamines, NMDA receptor modulators, and over -the- counter natural/herbal… …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction